Molecular and immunological characterization of Lp1, the 34 kDa outer membrane lipoprotein of Pseudomonas aeruginosa

References

Cordwell S.J. 2004. Exploring and exploiting bacterial proteomes. Methods Mol. Biol. 266: 115–135.10.1385/1-59259-763-7:115Suche in Google Scholar

Cryz S.R. Jr, Furer E. & Germanier R. 1983. Passive protection against Pseudomonas aeruginosa infection in an experimental leucopenic mouse model. Infect. Immun. 40: 659–664.10.1128/iai.40.2.659-664.1983Suche in Google Scholar

Cryz S.J. Jr, Sadoff J.C., Ohmann D. & Futer E. 1988. Characterization of the human immune response to a Pseudomonas aeruginosa 0-polysaccharide–toxin A conjugate vaccine. J. Lab. Clin. Med. 111: 701–707.Suche in Google Scholar

Deich R.A., Metcalf B.J., Finn C.W., Farley J.E. & Green B.A. 1988. Cloning of genes encoding a 15,000 dalton peptidoglycan associated outer membrane lipoprotein and an antigenically related 15,000 dalton protein from Haemophilus influenzae. J. Bacteriol. 170: 489–498.10.1128/jb.170.2.489-498.1988Suche in Google Scholar

Engleberg N.C., Howe D.C., Rogers J.E., Arroyo J. & Eisenstein B.I. 1991. Characterization of a Legionella pneumophila gene encoding a lipoprotein antigen. Mol. Microbiol. 5: 2021–2029.10.1111/j.1365-2958.1991.tb00824.xSuche in Google Scholar

Firoved A.M., Ornatowski W. & Deretic V. 2004. Microarray analysis reveals induction of lipoprotein genes in mucoid Pseudomonas aeruginosa: implications for inflammation in cystic fibrosis. Infect. Immun. 72: 5012–5018.10.1128/IAI.72.9.5012-5018.2004Suche in Google Scholar

Halegoua S., Hirashima A. & Inouye M. 1974. Existence of a free form of a specific membrane lipoprotein in gram–negative bacteria. J. Bacteriol. 120: 1204–1208.10.1128/jb.120.3.1204-1208.1974Suche in Google Scholar

Klade C.S. 2002. Proteomics approaches towards antigen discovery and vaccine development. Curr. Opin. Mol. Ther. 4: 216–223.Suche in Google Scholar

Lewenza S., Gardy J.L., Brinkman F.S. & Hancock R.E. 2005. Genome–wide identification of Pseudomonas aeruginosa exported proteins using a consensus computational strategy combined with a laboratory–based PhoA fusion screen. Genome Res. 15: 321–329.10.1101/gr.3257305Suche in Google Scholar

Liang M.D., Bagchi A., Warren H.S., Tehan M.M., Trigilio J.A., Beasley–Topliffe L.K., Tesini B.L., Lazzaroni J.C., Fenton M.J. & Hellman J. 2005. Bacterial peptidoglycan–associated lipoprotein: a naturally occurring toll–like receptor 2 agonist that is shed into serum and has synergy with lipopolysaccharide. J. Infect. Dis. 191: 939–948.10.1086/427815Suche in Google Scholar

Lim A. Jr, De Vos D., Brauns M., Mossialos D., Gaballa A., Qing D. & Cornelis P. 1997. Molecular and immunological characterization of OprL, the 18 kDa outer–membrane peptidoglycan–associated I ipoprotein (PAL) of Pseudomonas aeruginosa. Microbiology 143: 1709–1716.10.1099/00221287-143-5-1709Suche in Google Scholar

Lyczak J.B., Cannon C.L. & Pier G.B. 2000. Establishment of P. aeruginosa infection: lesions from a versatile opportunist. Microbes Infect. 2: 1051–1060.10.1016/S1286-4579(00)01259-4Suche in Google Scholar

Lyczak J.B., Cannon C.L. & Pier G.B. 2002. Lung infection associated with cystic fibrosis. Clin. Microbiol. Rev. 15: 194–222.10.1128/CMR.15.2.194-222.2002Suche in Google Scholar PubMed PubMed Central

Mizuno T. & Kageyama M. 1979. Isolation and characterization of a major outer membrane protein of Pseudomonas aeruginosa. J. Biochem. 85: 115–122.10.1093/oxfordjournals.jbchem.a132300Suche in Google Scholar PubMed

Moira M.B., Ghoneim A.T.M., Littlewood J.M. & Losowsky M.S. 1986. Development of enzyme linked immunosorbent assay (ELISA) to detect antibodies to Pseudomonas aeruginosa cell surface antigens in sera of patients with cystic fibrosis. J. Clin. Pathol. 39: 1124–1129.10.1136/jcp.39.10.1124Suche in Google Scholar PubMed PubMed Central

Mollenkopf H.J., Grode L., Mattow J., Stein M., Mann P. & Knapp B. 2004. Application of mycobacterial proteomics to vaccine design: improved protection by Mycobacterium bovis BCG prime–Rv3407 DNA boost vaccination against tuberculosis. Infect. Immun. 72: 1–9.10.1128/IAI.72.11.6471-6479.2004Suche in Google Scholar PubMed PubMed Central

Mutharia L.M., Nicas T.I. & Hancock R.E.W. 1982. Outer membrane proteins of Pseudomonas aeruginosa serotype strains. J. Infect. Dis. 146: 770–779.10.1093/infdis/146.6.770Suche in Google Scholar PubMed

Pennington J.E., Hickey W.F., Blackwood F. & Arnaut M. 1981. Active immunization with lipopolysaccharide Pseudomonas antigen for chronic Pseudomonas bronchopneumonia in guinea pigs. J. Clin. Invest. 68: 1140–1148.10.1172/JCI110358Suche in Google Scholar PubMed PubMed Central

Priebe G.P., Meluleni G.J., Coleman F.T., Goldberg J.B. & Pier G.B. 2003. Protection against fatal Pseudomonas aeruginosa pneumonia in mice after nasal immunization with a live, attenuated aroA deletion mutant. Infect. Immun. 71: 1453–1461.10.1128/IAI.71.3.1453-1461.2003Suche in Google Scholar PubMed PubMed Central

Remans K., Vercammen K., Bodilis J. & Cornelis P. 2010. Genome–wide analysis and literature–based survey of lipoproteins in Pseudomonas aeruginosa. Microbiology 156: 2597–2607.10.1099/mic.0.040659-0Suche in Google Scholar PubMed

Roe E.A. & Jones R.J. 1983. Immunization of burned patients against Pseudomonas aeruginosa infection at Safdarjang Hospital, New Delhi. Rev. Infect. Dis. 5: 922–930.10.1093/clinids/5.Supplement_5.S922Suche in Google Scholar

Rosenqvist E., Wedege E., Hoiby E.A. & Froholm L.O. 1990. Serogroup determination of Neisseria meningitidis by wholecell ELISA, dot–blotting and agglutination. APMIS 98: 501–506.10.1111/j.1699-0463.1990.tb01063.xSuche in Google Scholar

Scarselli M., Giuliani M.M., Adu–Bobie J., Pizza M. & Rappuoli R. 2005. The impact of genomics on vaccine design. Trends Biotechnol. 23: 84–91.10.1016/j.tibtech.2004.12.008Suche in Google Scholar

Schaad, U.B., Lang A.B., Wedgwood J., Ruedeberg A. & J.U., Flirer E. & Cryz S.J. 1991. Safety and immunogenicity of Pseudomonas aeruginosa conjugate A vaccine in cystic fibrosis. Lancet. 228: 1236–1237.10.1016/0140-6736(91)92103-9Suche in Google Scholar

Stanislavsky E.S. & Lam J.S. 1997. Pseudomonas aeruginosa antigens as a potential vaccines. FEMS Microbiol. Rev. 21: 243–277.10.1111/j.1574-6976.1997.tb00353.xSuche in Google Scholar

Tibor, A., Weynants, V., Denoel, P., Lichtfouse, B., De Bolle, X., Saman, E., Limet, J. & Letesson, J. J. 1994. Molecular cloning, nucleotide sequence, and occurrence of a 16.5 kilo–dalton outer membrane protein of Brucella abortus with similarity to PAL lipoproteins. Infect. Immun. 62: 3633–3639.10.1128/iai.62.9.3633-3639.1994Suche in Google Scholar

Towbin H., Staehelin T. & Gordon J. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 76: 4350–4354.10.1073/pnas.76.9.4350Suche in Google Scholar

Vytvytska O., Nagy E., Bluggel M., Meyer H.E., Kurzbauer R. & Huber L.A. 2002. Identification of vaccine candidate antigens of Staphylococcus aureus by serological proteome analysis. Proteomics 2: 580–90.10.1002/1615-9861(200205)2:5<580::AID-PROT580>3.0.CO;2-GSuche in Google Scholar

Winsor G.L., Van Rossum T., Lo R., Khaira B., Whiteside M.D., Hancock R.E. & Brinkman F.S. 2009. Pseudomonas genome database: facilitating user–friendly, comprehensive comparisons of microbial genomes. Nucleic Acids Res. 37: D483-D488.10.1093/nar/gkn861Suche in Google Scholar

Ying T., Wang H., Li M., Wang J. & Shi Z. 2005. Immunoproteomics of outer membrane proteins and extracellular proteins of Shigella flexneri 2a 2457T. Proteomics 5: 77–93.10.1002/pmic.200401326Suche in Google Scholar